Ganirelix (124904-93-4)

Description

Ganirelix (124904-93-4) video

 

Ganirelix (124904-93-4) Description

Ganirelix is an injectable competitive gonadotropin-releasing hormone antagonist (a decapeptide GnRH antagonist). It is primarily used in assisted reproduction to control ovulation. The drug works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of LH and FSH. Ganirelix is used in fertility treatment to prevent premature ovulation that could result in the harvesting of eggs that are too immature to be used in procedures such as in vitro fertilisation. Ganirelix is marketed by Merck & Co., Inc. as Orgalutran.

Ganirelix is rapidly absorbed following subcutaneous injection with maximum serum concentrations reached approximately one hour after dosing.

Ganirelix (124904-93-4) Specifications

Product Name	Ganirelix
Chemical Name	Ac-DNal-DCpa-DPal-Ser-Tyr-DHar(Et2)-Leu-Har(Et2)-Pro-DAla -NH2;Ganirelixum
Brand Name	Orgalutran, Antagon
Drug Class	Peptide
CAS Number	124904-93-4 (123246-29-7)
InChIKey	GJNXBNATEDXMAK-PFLSVRRQSA-N
Molecular Formula	C80H113ClN18O13
Molecular Weight	1570.347 g/mol
Monoisotopic Mass	1568.842 g/mol
Melting Point	N/A
Biological Half-Life	16.2 hours
Color	White
Solubility	0.25mg/ml~30mg/ml in DMSO and DMF
Storage Temperature	−20°C
Application	a Gonadotropin Releasing Hormone Antagonist, used in assisted reproduction to control ovulation.

 

---